Beth Walton Memorial 5K Run/Walk for Ovarian Cancer

Come out to Wheaton Regional Park in Maryland on Sunday, June 10 at 8:00 a.m. to run 5K or walk one mile at the third annual Beth Walton 5K Run/Walk. This event raises money to fund a reliable, early detection test for ovarian cancer.

For more information and to register, visit: www.bethwalton5k.com.



Join FORCE for cocktails & dessert, museum mingling,
fabulous raffle prizes at the EXCLUSIVE MOVIE SCREENING of FIVE

Saturday, April 28, 2012 @ 7:30pm
The Ratner Museum
10001 Old Georgetown Road, Bethesda
RSVP to www.facingourrisk.org/RSVPDC

The 3rd Johns Hopkins Ovarian Cancer Symposium:

John Hopkins Medical Institutions in Baltimore is sponsoring a symposium on "Advances in Studying the Cell of Origin & Biology in Ovarian Cancer" on May 17 and 18.

For more information and to register, CLICK HERE.

Is Your Body Talking? Take Time to Listen

Ovarian and Endometrial Cancer Survivor Stories

DC Department of Health, DC Cancer Consortium, and OGCC/Rhonda's Club partnered to conduct an interpersonal study of women who have survived ovarian and endometrial cancers. To watch videos of interviews, click the clip above.

VOLUNTEER TO RAISE AWARENESS OF OVARIAN CANCER

Join OGCC’s Survivors Teaching Students program, part of a nationwide campaign to bring ovarian cancer survivors into medical school classrooms to raise awareness of symptoms and share experiences with treatment.  We help you develop your story.  Our next training session will be on Saturday, May 19 from 11:45 to 4:45 at the Potomac Community Center, 11315 Falls Road in Potomac, Maryland.

For more information about the program or to volunteer, please contact Fran Stolusky at warren.fran@verizon.net or 301-299-9369.

SURVIVOR EDUCATION PROGRAM

The Future of Ovarian & Gynecologic Cancer, presented by Dr. Michael V. Seiden, MD, PhD, President and CEO of Fox Chase Cancer Center, Philadelphia, PA, to Rhonda's Club on September 12, 2011.

Click on the image above to watch the video.

Click here to download slides accompanying Dr. Michael V. Seiden's presentation.

view our calendar of events >

MEDICAL NEWS

Cervical Cancer Screening

The U.S. Preventive Services Task Force announced on March 14 its final recommendation on screening for cervical cancer. For more information, CLICK HERE.

Ovarian Cancer Advocates Troubled by FDA Decision on Avastin and Breast Cancer
Posted by the Ovarian Cancer National Alliance (OCNA)

On November 18, the Food and Drug Administration (FDA) announced that it would remove metastatic breast cancer from the label for Avastin (bevacizumab). This decision follows recommendations made in June by the FDA Oncologic Drugs Advisory Committee. Responding to today’s decision, OCNA CEO Karen Orloff Kaplan, MSW, MPH, ScD, expressed concern that the removal of metastatic breast cancer from the Avastin label could negatively affect women with ovarian cancer, for whom the drug is used off-label.  read more >>

Ovarian Cancer Patients with BRCA Mutations May Fare Better than Non-Carriers

A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than women with BRCA1 mutations. The results were published online today in JAMA. Inherited mutations in BRCA1 and BRCA2 are the strongest known genetic risk factors for breast cancer and epithelial ovarian cancer, the most common form of ovarian cancer. To read more click here.

more resources >